Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biotechnol ; 218: 53-63, 2016 Jan 20.
Article in English | MEDLINE | ID: mdl-26654938

ABSTRACT

Industrial fed-batch cultivation of mammalian cells is used for the production of therapeutic proteins such as monoclonal antibodies. Besides medium ensuring initial growth, feeding is necessary to improve growth, viability and antibody production. Established processes include a slight acidic main feed and a separate alkaline feed containing l-tyrosine and l-cysteine. Since l-cysteine is not stable at neutral pH, a new derivative, S-sulfocysteine, was tested in neutral pH feeds. In small scale fed-batch processes, the S-sulfocysteine process yielded a comparable maximum viable cell density, prolonged viability and increased titer compared to the two feed system. Bioreactor experiments confirmed the increase in specific productivity. In depth characterization of the monoclonal antibody indicated no change in the glycosylation, or charge variant pattern whereas peptide mapping experiments were not able to detect any integration of the modified amino acid in the sequence of the monoclonal antibody. Finally, the mechanism of action of S-sulfocysteine was investigated, and results pointed out the anti-oxidative potential of the molecule, mediated through an increase in superoxide dismutase enzyme levels and in the total intracellular glutathione pool. Finally, we propose that the increase in specific productivity obtained in the S-sulfocysteine process results from the anti-oxidative properties of the molecule.


Subject(s)
Antioxidants/pharmacology , Batch Cell Culture Techniques/methods , Culture Media , Cysteine/analogs & derivatives , Amino Acids/metabolism , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/drug effects , Antibodies, Monoclonal/metabolism , Antioxidants/metabolism , Bioreactors , CHO Cells , Cricetinae , Cricetulus , Cysteine/metabolism , Cysteine/pharmacology , Glutathione/metabolism , Glycosylation/drug effects , Hydrogen-Ion Concentration , Peptide Mapping , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...